Lv2
140 积分 2023-07-04 加入
Synthetic and Natural Radioprotective Agents: Recent Status and their Underlying Mechanism of Action
25天前
已完结
Repurposing of Various Current Medicines as Radioprotective Agents
25天前
已完结
Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer
9个月前
已完结
Radiotherapy plus camrelizumab and irinotecan for oligometastatic esophageal squamous cell carcinoma patients after first-line immunotherapy plus chemotherapy failure: An open-label, single-arm, phase II trial
9个月前
已完结
Clinical and genetic characteristics of patients with TRG 0 and TRG III in esophageal squamous cell carcinoma after neoadjuvant therapy
9个月前
已完结
An Open‐Label Phase II Trial of Pembrolizumab, an Immune Checkpoint Inhibitor Alone or in Combination With Oral Azacitidine as Second‐Line Therapy for Advanced Head and Neck Squamous Cell Cancers
9个月前
已完结
Response-Adaptive Surgical Timing in neoadjuvant immunotherapy demonstrates enhanced pathologic treatment response in Head and Neck Squamous Cell Carcinoma
9个月前
已完结
Combined Metronomic Chemo-immunotherapy (CMCI) in Head and Neck Cancers–An Experience from a Developing Country
9个月前
已完结
Phase Ib study of SCT200 combined with paclitaxel or docetaxel in patients with recurrent or metastatic head and neck squamous cell carcinoma following platinum-based chemotherapy and PD-1 antibody
9个月前
已完结
Predicting EGFR and PD-L1 Status in NSCLC Patients Using Multitask AI System Based on CT Images
皖公网安备34019202002308
